Status:
COMPLETED
A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
Phase I, randomised, open label, 3-period crossover study in healthy male subjects to investigate the effect of food on the pharmacokinetics of AZD8931 and to investigate the safety and tolerability o...
Eligibility Criteria
Inclusion
- Provision of written informed consent
- Body mass index (BMI) between 19 and 30 kg/m2
Exclusion
- Use of any prescribed or non-prescribed medication (including analgesics, herbal remedies, vitamins and minerals) during the two weeks prior to the first administration of investigational product
- Administration of another investigational medicinal product in the 3 months before the start of dosing in this study
- Definite or suspected clinically relevant personal history of adverse drug reactions, or drug hypersensitivity
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00879346
Start Date
March 1 2009
End Date
July 1 2009
Last Update
October 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Alderley Park, Cheshire, United Kingdom